Mortality among persons with schizophrenia in Sweden: An epidemiological study

References

• Ahlström, CH. Mortality in mental hospitals with especial regard to tuberculosis. Acta Psychiat Neurol 1942;Suppl 42.
   Google Scholar
• Mortensen PB, Juel K. Mortality and causes of death in schizophrenic patients in Denmark. Acta Psychiatr Scand 1990; 81: 372–77
   PubMed Web of Science ®Google Scholar
• Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177: 212–17
   PubMed Web of Science ®Google Scholar
• Allebeck P, Wistedt B. Mortality in schizophrenia. A ten-year follow-up based on the Stockholm County inpatient register. Arch Gen Psychiatry 1986; 43: 650–3
   PubMedGoogle Scholar
• Buda M, Tsuang MT, Fleming JA. Causes of death in DSM-III schizophrenics and other psychotics (atypical group). A comparison with the general population. Arch Gen Psychiatry 1988; 45: 283–5
   Google Scholar
• Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry 1993; 163: 183–9
   PubMed Web of Science ®Google Scholar
• Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry 1998; 173: 11–53
   PubMed Web of Science ®Google Scholar
• Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry 1997; 171: 502–8
   PubMed Web of Science ®Google Scholar
• Ösby U, Correia N, Brandt L, Ekbom A, Sparen P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res 2000; 45: 21–8
   PubMed Web of Science ®Google Scholar
• Joukamaa M, Heliovaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V. Mental disorders and cause-specific mortality. Br J Psychiatry 2001; 179: 498–502
   PubMed Web of Science ®Google Scholar
• Tsuang MT, Woolson RF, Fleming JA. Causes of death in schizophrenia and manic-depression. Br J Psychiatry 1980; 136: 239–42
   PubMed Web of Science ®Google Scholar
• Mortensen PB. The occurrence of cancer in first admitted schizophrenic patients. Schizophr Res 1994; 12: 185–94
   PubMedGoogle Scholar
• Cohen M, Dembling B, Schorling J. The association between schizophrenia and cancer: A population-based mortality study. Schizophr Res 2002; 57: 139–46
   PubMed Web of Science ®Google Scholar
• Davidson M. Risk of cardiovascular disease and sudden death in schizophrenia. J Clin Psychiatry 2002; 63: 5–11
   PubMedGoogle Scholar
• Ryan MC, Thakore JH. Physical consequences of schizophrenia and its treatment: The metabolic syndrome. Life Sci 2002; 71: 239–57
   PubMed Web of Science ®Google Scholar
• Kohen D. Diabetes mellitus and schizophrenia: Historical perspective. Br J Psychiatry Suppl 2004; 47: S64–6
   Google Scholar
• Busche C, Holt R. Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia. Br J Psychiatry Suppl 2004; 47: S67–71
   Google Scholar
• Snaith RP. Antipsychotic polypharmacy and early death. Br J Psychiatry 1999; 174: 368–9
   Google Scholar
• Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001; 58: 1161–7
   PubMed Web of Science ®Google Scholar
• Montout C, Casadebaig F, Lagnaoui R, Verdoux H, Philippe A, Begaud B, et al. Neuroleptics and mortality in schizophrenia: Prospective analysis of deaths in a French cohort of schizophrenic patients. Schizophr Res 2002; 57: 147
   PubMed Web of Science ®Google Scholar
• Howes O, Ohlsen R, Pilowsky LS. Effect of clozapine on mortality. Br J Psychiatry 2003; 183: 460
   Google Scholar
• Lindström E, Bingefors K. Patient compliance with drug therapy in schizophrenia. Economic and clinical issues. Pharmacoeconomics 2000; 18: 106–24
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-III-R). American Psychiatric Association, Washington, DC 1987
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). American Psychiatric Association, Washington, DC 1994
   Google Scholar
• Widerlöv B, Lindström E, von Knorring L. One-year prevalence of long-term functional psychosis in three different areas of Uppsala. Acta Psychiatr Scand 1997; 96: 452–8
   PubMed Web of Science ®Google Scholar
• Lindström E, Widerlöv B, von Knorring L. The ICD-10 and DSM-IV diagnostic criteria and the prevalence of schizophrenia. Eur Psychiatru 1997; 12: 217–23
   Web of Science ®Google Scholar
• Wood JB, Evenson RC, Cho DW, Hagan BJ. Mortality variations among public mental health patients. Acta Psychiatr Scand 1985; 72: 218–29
   PubMed Web of Science ®Google Scholar
• Widerlöv B, Borga P, Cullberg J, Stefansson CG, Lindqvist G. Epidemiology of long-term functional psychosis in three different areas in Stockholm County. Acta Psychiatr Scand 1989; 80: 40–6
   PubMed Web of Science ®Google Scholar
• Oakley-Browne MA, Joyce PR, Wells JE, Bushnell JA, Hornblow AR. Christchurch Psychiatric Epidemiology Study, Part II: Six month and other period prevalences of specific psychiatric disorders. Aust N Z J Psychiatry 1989; 23: 327–40
   PubMed Web of Science ®Google Scholar
• Robins L, Regier D. Psychiatric disorders in America. The Epidemiologic Catchment area study. The Free Press, New York 1991
   Google Scholar
• Babigian HM, Odoroff CL. The mortality experience of a population with psychiatric illness. Am J Psychiatry 1969; 126: 470–80
   PubMed Web of Science ®Google Scholar
• Herrman HE, Baldwin JA, Christie D. A record-linkage study of mortality and general hospital discharge in patients diagnosed as schizophrenic. Psychol Med 1983; 13: 581–93
   PubMedGoogle Scholar
• Amaddeo F, Bisoffi G, Bonizzato P, Micciolo R, Tansella M. Mortality among patients with psychiatric illness. A ten-year case register study in an area with a community-based system of care. Br J Psychiatry 1995; 166: 783–8
   PubMed Web of Science ®Google Scholar
• Baxter DN. The mortality experience of individuals on the Salford Psychiatric Case Register. I. All-cause mortality. Br J Psychiatry 1996; 168: 772–9
   PubMed Web of Science ®Google Scholar
• Salokangas RK, Honkonen T, Stengard E, Koivisto AM. Mortality in chronic schizophrenia during decreasing number of psychiatric beds in Finland. Schizophr Res 2002; 54: 265–75
   PubMed Web of Science ®Google Scholar
• Maric N, Krabbendam L, Vollebergh W, de Graaf R, van Os J. Sex differences in symptoms of psychosis in a non-selected, general population sample. Schizophr Res 2003; 63: 89–95
   PubMed Web of Science ®Google Scholar
• Black DW, Winokur G. Age, mortality and chronic schizophrenia. Schizophr Res 1988; 1: 267–72
   PubMed Web of Science ®Google Scholar
• Saugstad LF, Odegard O. Mortality in psychiatric hospitals in Norway 1950–74. Acta Psychiatr Scand 1979; 59: 431–47
   PubMedGoogle Scholar
• Osby U, Correia N, Bradt L, Ekbom A, Sparen P. Time trends in schizophrenia mortality in Stockholm county, Sweden: Cohort study. BMJ 2000; 321: 483–4
   PubMed Web of Science ®Google Scholar
• Lindelius R, Kay DWK. Some Changes in the pattern of mortality in schizophrenia, in Sweden. Acta Psychiatr Scand 1973; 19: 315–23
   Google Scholar
• Lyon ER. A review of the effects of nicotine on schizophrenia and antipsychotic medications. Psychiatr Serv 1999; 50: 1346–50
   PubMed Web of Science ®Google Scholar
• Dalack GW, Healy DJ, Meador-Woodruff JH. Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings. Am J Psychiatry 1998; 155: 1490–501
   PubMed Web of Science ®Google Scholar
• Addy N, Levin ED. Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats. Neuropsychopharmacology 2002; 27: 534–41
   PubMed Web of Science ®Google Scholar
• Nomikos GG, Schilström B, Hildebrand BE, Panagis G, Grehoff J, Svensson TH. Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness. Behav Brain Res 2000; 113: 97–103
   Google Scholar
• Dawe S, Gerada C, Russell MA, Gray JA. Nicotine intake in smokers increases following a single dose of haloperidol. Psychopharmacology (Berl) 1995; 117: 110–15
   PubMed Web of Science ®Google Scholar
• Anderson C, Connelly J, Johnstone EC, Owens DG. Disabilities and circumstances of schizophrenic patients—A follow-up study. Cause of death. Br J Psychiatry Suppl 1991; 30–3: 44–6
   Google Scholar
• Mortensen PB. Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients. Acta Psychiatr Scand 1987; 75: 585–90
   PubMed Web of Science ®Google Scholar
• Tsuang MT, Woolson RF, Fleming JA. Schizophrenia and cancer death. Lancet 1980; 1: 480–1
   Google Scholar
• Rutz W, von Knorring L, Wålinder J. Frequency of suicide on Gotland after systematic postgraduate education of general practitioners. Acta Psychiatr Scand 1989; 80: 151–4
   PubMed Web of Science ®Google Scholar
• Ødegaard, Ø. The excess mortality of the insane. Acta Psychiatr Neurolog 1952;353–67.
   Google Scholar
• Tsuang MT, Woolsor RF, Fleming JA. Causes of death in schizophrenia and manic-depression. Br J Psychiatry 1980; 136: 239–42
   PubMed Web of Science ®Google Scholar
• Black DW, Winokur G. Age mortality and chronic schizophrenia. Schizophr Res 1988; 1: 267–72
   PubMed Web of Science ®Google Scholar
• Newman SC, Bland RC. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry 1991; 36: 239–45
   PubMed Web of Science ®Google Scholar